LAMIVUDINE ORAL

LAMIVUDINE ORAL was reported 25273 times

LAMIVUDINE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PINEALOBLASTOMA 74 0.7957
1 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 101 0.7829
2 CSF HIV VIRUS IDENTIFIED 18 0.7826
3 CONGENITAL NEOPLASM 21 0.7778
4 GENOTYPE DRUG RESISTANCE TEST 33 0.6735
5 CSF HIV ESCAPE SYNDROME 83 0.6014
6 HIV VIRAEMIA 115 0.5476
7 ULTRASOUND ANTENATAL SCREEN 51 0.5312
8 VIRAL MUTATION IDENTIFIED 1652 0.4481
9 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 118 0.4245
10 GENETIC POLYMORPHISM 24 0.4211
11 IMMUNE RECONSTITUTION SYNDROME 502 0.3888
12 TOTAL LUNG CAPACITY INCREASED 103 0.3787
13 VIROLOGIC FAILURE 1902 0.3533
14 HIV ASSOCIATED NEPHROPATHY 17 0.3333
15 AIDS ENCEPHALOPATHY 19 0.3276
16 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 33 0.2973
17 GRANULOMATOUS ROSACEA 14 0.2857
18 AIDS RELATED COMPLICATION 18 0.2769
19 MITOCHONDRIAL TOXICITY 218 0.2655
20 BIRTH MARK 53 0.2548
21 CONGENITAL TERATOMA 20 0.2326
22 ECTOPIC KIDNEY 22 0.2316
23 LIPODYSTROPHY ACQUIRED 476 0.2240
24 BLOOD HIV RNA INCREASED 392 0.2160
25 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 71 0.2119
26 HEPATITIS B DNA INCREASED 139 0.2062
27 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 103 0.1969
28 PATHOGEN RESISTANCE 1739 0.1906
29 HEPATITIS B VIRUS 15 0.1875
30 RETINOBLASTOMA 20 0.1835
31 VERTICAL INFECTION TRANSMISSION 19 0.1681
32 ERGOT POISONING 21 0.1680
33 KAPOSI'S SARCOMA 75 0.1494
34 CONGENITAL UMBILICAL HERNIA 55 0.1475
35 URINE PHOSPHORUS INCREASED 16 0.1468
36 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 704 0.1411
37 DANDY-WALKER SYNDROME 34 0.1313
38 HEPATITIS B REACTIVATION 396 0.1246
39 CD4 LYMPHOCYTES INCREASED 28 0.1202
40 FANCONI SYNDROME ACQUIRED 211 0.1201
41 MITOCHONDRIAL MYOPATHY 24 0.1101
42 HEPATITIS B DNA ASSAY POSITIVE 14 0.1094
43 ACQUIRED GENE MUTATION 142 0.1083
44 TRISOMY 18 39 0.1024
45 DEXTROCARDIA 19 0.1011
46 THYMUS ENLARGEMENT 16 0.1000
47 RENAL TUBULAR DYSFUNCTION 56 0.0991
48 MACROCEPHALY 38 0.0979
49 FOETAL GROWTH ABNORMALITY 15 0.0955
50 FANCONI SYNDROME 135 0.0954
51 HYPOPHOSPHATAEMIC OSTEOMALACIA 25 0.0947
52 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 17 0.0934
53 FOETAL EXPOSURE DURING DELIVERY 63 0.0929
54 GENOTYPE DRUG RESISTANCE TEST POSITIVE 95 0.0924
55 HEPATITIS B SURFACE ANTIGEN POSITIVE 25 0.0912
56 MENINGOMYELOCELE 52 0.0867
57 OSTEOMALACIA 131 0.0847
58 HIV INFECTION 254 0.0842
59 HEPATITIS B 507 0.0841
60 CHRONIC DISEASE 21 0.0824
61 HYDROPS FOETALIS 50 0.0816
62 LIPOATROPHY 77 0.0809
63 PSYCHIATRIC DECOMPENSATION 156 0.0798
64 MITOCHONDRIAL CYTOPATHY 35 0.0795
65 CD4 LYMPHOCYTES DECREASED 161 0.0751
66 PNEUMOCYSTIS CARINII PNEUMONIA 15 0.0739
67 DRUG RESISTANCE 1883 0.0732
68 HYPOURICAEMIA 21 0.0724
69 MENINGITIS CRYPTOCOCCAL 123 0.0703
70 ACQUIRED IMMUNODEFICIENCY SYNDROME 36 0.0694
71 VIRAEMIA 94 0.0678
72 NODULAR REGENERATIVE HYPERPLASIA 43 0.0670
73 NEUTROPENIA NEONATAL 15 0.0670
74 POLYDACTYLY 75 0.0647
75 PORTAL HYPERTENSIVE GASTROPATHY 36 0.0638
76 FACIAL WASTING 17 0.0632
77 MENINGITIS TUBERCULOUS 34 0.0608
78 CHRONIC HEPATITIS B 19 0.0599
79 MULTIPLE-DRUG RESISTANCE 186 0.0599
80 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 27 0.0578
81 NEURAL TUBE DEFECT 42 0.0578
82 ATRIOVENTRICULAR SEPTAL DEFECT 26 0.0553
83 GENE MUTATION 109 0.0550
84 GASTROSCHISIS 26 0.0546
85 VIRAL LOAD INCREASED 210 0.0540
86 CUSHING'S SYNDROME 37 0.0532
87 TRISOMY 21 67 0.0532
88 BONE METABOLISM DISORDER 16 0.0532
89 BRAIN STEM STROKE 25 0.0507
90 CONGENITAL HYDROCEPHALUS 25 0.0493
91 PSYCHOMOTOR SKILLS IMPAIRED 128 0.0488
92 RETINAL TOXICITY 50 0.0485
93 LIPOHYPERTROPHY 30 0.0482
94 OPHTHALMOPLEGIA 76 0.0481
95 PORTAL HYPERTENSION 145 0.0470
96 BIOPSY LIVER ABNORMAL 14 0.0467
97 VISCERAL LEISHMANIASIS 32 0.0443
98 ACUTE HEPATITIS B 14 0.0422
99 CYTOMEGALOVIRUS CHORIORETINITIS 81 0.0415
100 ANAEMIA NEONATAL 20 0.0415
101 GLYCOSURIA 56 0.0414
102 CRYPTOCOCCOSIS 67 0.0411
103 TEMPERATURE REGULATION DISORDER 91 0.0408
104 CEREBRAL TOXOPLASMOSIS 38 0.0407
105 CLEFT LIP AND PALATE 45 0.0403
106 HYPOMANIA 148 0.0402
107 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 44 0.0400
108 NECROTISING ENTEROCOLITIS NEONATAL 16 0.0394
109 JAUNDICE CHOLESTATIC 139 0.0393
110 STILLBIRTH 190 0.0393
111 TOXIC OPTIC NEUROPATHY 17 0.0392
112 ARNOLD-CHIARI MALFORMATION 36 0.0377
113 DEATH NEONATAL 52 0.0374
114 NON-CIRRHOTIC PORTAL HYPERTENSION 14 0.0372
115 DEPRESSION SUICIDAL 125 0.0361
116 DEPRESSIVE SYMPTOM 124 0.0351
117 VANISHING BILE DUCT SYNDROME 39 0.0350
118 HYPERLACTACIDAEMIA 92 0.0343
119 HEPATITIS A 29 0.0342
120 HEPATIC FIBROSIS 114 0.0332
121 CONGENITAL FOOT MALFORMATION 15 0.0330
122 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
123 PLEOCYTOSIS 19 0.0326
124 FOETAL DEATH 166 0.0320
125 BASEDOW'S DISEASE 15 0.0319
126 HIV TEST POSITIVE 21 0.0318
127 TEARFULNESS 136 0.0316
128 EXPOSURE DURING BREAST FEEDING 104 0.0314
129 RENAL TUBULAR DISORDER 88 0.0312
130 LYMPH NODE TUBERCULOSIS 23 0.0309
131 SICKLE CELL DISEASE 14 0.0303
132 SYPHILIS 22 0.0303
133 MICROGNATHIA 15 0.0300
134 GASTRIC VARICES 14 0.0297
135 NEURODEVELOPMENTAL DISORDER 20 0.0296
136 PULMONARY TUBERCULOSIS 126 0.0295
137 DYSLIPIDAEMIA 148 0.0291
138 BLOOD BILIRUBIN UNCONJUGATED INCREASED 21 0.0289
139 HISTOPLASMOSIS 51 0.0288
140 MOLLUSCUM CONTAGIOSUM 15 0.0278
141 LIPIDS ABNORMAL 20 0.0276
142 TOXOPLASMOSIS 29 0.0269
143 MYCOBACTERIUM AVIUM COMPLEX INFECTION 72 0.0268
144 MYCOBACTERIAL INFECTION 46 0.0267
145 VOLVULUS 61 0.0257
146 HEPATOSPLENOMEGALY 66 0.0257
147 RENAL TUBULAR ACIDOSIS 56 0.0256
148 MALARIA 18 0.0255
149 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 27 0.0250
150 SKULL MALFORMATION 16 0.0249
151 BLOOD LACTIC ACID INCREASED 130 0.0247
152 FAT TISSUE INCREASED 35 0.0241
153 VARICES OESOPHAGEAL 73 0.0241
154 OESOPHAGEAL VARICES HAEMORRHAGE 52 0.0239
155 NECROTISING RETINITIS 15 0.0234
156 RHINITIS ALLERGIC 103 0.0231
157 SPINA BIFIDA 48 0.0230
158 CENTRAL OBESITY 17 0.0230
159 CSF PROTEIN INCREASED 19 0.0229
160 PNEUMOCYSTIS JIROVECI PNEUMONIA 51 0.0229
161 DIAPHRAGMATIC HERNIA 14 0.0226
162 MICROALBUMINURIA 17 0.0225
163 FOETAL EXPOSURE DURING PREGNANCY 1814 0.0223
164 SARCOIDOSIS 106 0.0223
165 BONE MARROW TOXICITY 26 0.0219
166 PYELOCALIECTASIS 21 0.0219
167 LYMPHADENITIS 52 0.0215
168 PNEUMOCOCCAL SEPSIS 14 0.0213
169 NASAL POLYPS 105 0.0213
170 DELAYED GRAFT FUNCTION 15 0.0211
171 HYPOPHOSPHATAEMIA 155 0.0210
172 LYMPHOCYTIC INFILTRATION 21 0.0208
173 HYDROCELE 22 0.0206
174 NEPHROPATHY TOXIC 225 0.0200
175 EYELID PTOSIS 203 0.0200
176 NON-HODGKIN'S LYMPHOMA 26 0.0199
177 CONGENITAL HYDRONEPHROSIS 14 0.0196
178 DEVELOPMENTAL HIP DYSPLASIA 16 0.0192
179 DISSEMINATED TUBERCULOSIS 49 0.0191
180 EROSIVE DUODENITIS 15 0.0187
181 CRYPTORCHISM 21 0.0187
182 POSTPARTUM HAEMORRHAGE 25 0.0185
183 ANAEMIA MACROCYTIC 39 0.0183
184 SCHIZOPHRENIA 222 0.0182
185 INTRA-UTERINE DEATH 29 0.0181
186 STRONGYLOIDIASIS 29 0.0179
187 OPPORTUNISTIC INFECTION 33 0.0178
188 LIVER TRANSPLANT REJECTION 32 0.0178
189 HYPOSPADIAS 37 0.0178
190 NECROTISING COLITIS 22 0.0174
191 LIVE BIRTH 145 0.0173
192 OESOPHAGEAL CANDIDIASIS 69 0.0173
193 HYPERTRIGLYCERIDAEMIA 100 0.0171
194 CALCULUS URINARY 26 0.0169
195 VENTRICULAR SEPTAL DEFECT 94 0.0164
196 BRONCHIECTASIS 110 0.0163
197 ATYPICAL MYCOBACTERIAL INFECTION 23 0.0163
198 PORTAL VEIN THROMBOSIS 52 0.0161
199 BLOOD TRIGLYCERIDES ABNORMAL 14 0.0160
200 HYPERPHOSPHATAEMIA 34 0.0158
201 BLOOD AMYLASE INCREASED 27 0.0158
202 CACHEXIA 81 0.0157
203 SMALL FOR DATES BABY 78 0.0157
204 HEPATOTOXICITY 348 0.0156
205 OROPHARYNGEAL CANDIDIASIS 14 0.0155
206 CARDIAC MURMUR 133 0.0154
207 NEONATAL DISORDER 24 0.0151
208 MATERNAL DRUGS AFFECTING FOETUS 115 0.0150
209 FOETAL GROWTH RESTRICTION 91 0.0150
210 PREMATURE RUPTURE OF MEMBRANES 36 0.0149
211 HEPATORENAL SYNDROME 25 0.0148
212 PLACENTAL DISORDER 14 0.0148
213 BLOOD PHOSPHORUS DECREASED 54 0.0148
214 ABDOMINAL SEPSIS 13 0.0148
215 ABORTION INDUCED 139 0.0147
216 ENTHESOPATHY 23 0.0147
217 HEPATITIS E 23 0.0146
218 GENITAL HERPES 22 0.0144
219 NEPHRITIS INTERSTITIAL 18 0.0142
220 HEPATOMEGALY 139 0.0141
221 OPTIC ATROPHY 23 0.0141
222 NEUROMYOPATHY 15 0.0141
223 PSYCHOMOTOR RETARDATION 39 0.0139
224 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 114 0.0138
225 LOW BIRTH WEIGHT BABY 109 0.0137
226 EXPOSURE DURING PREGNANCY 847 0.0136
227 HEART TRANSPLANT REJECTION 14 0.0135
228 CAESAREAN SECTION 157 0.0135
229 KLEBSIELLA SEPSIS 15 0.0133
230 PREGNANCY ON CONTRACEPTIVE 19 0.0130
231 CEREBELLAR SYNDROME 28 0.0128
232 WHITE MATTER LESION 16 0.0127
233 SECONDARY ADRENOCORTICAL INSUFFICIENCY 19 0.0126
234 COCCIDIOIDOMYCOSIS 15 0.0126
235 TREATMENT FAILURE 1019 0.0123
236 ATRIAL SEPTAL DEFECT 103 0.0123
237 HEPATIC ENCEPHALOPATHY 114 0.0122
238 PREMATURE BABY 366 0.0121
239 HISTOPLASMOSIS DISSEMINATED 19 0.0120
240 PARAPARESIS 21 0.0118
241 PARADOXICAL DRUG REACTION 43 0.0117
242 CHOLESTATIC LIVER INJURY 26 0.0117
243 ENCEPHALITIS VIRAL 14 0.0115
244 BLOOD BILIRUBIN INCREASED 310 0.0115
245 TREATMENT NONCOMPLIANCE 624 0.0114
246 HYPERBILIRUBINAEMIA 118 0.0114
247 HEPATIC NEOPLASM MALIGNANT 24 0.0113
248 FOOD ALLERGY 87 0.0113
249 TALIPES 35 0.0113
250 DRUG INTERACTION 1780 0.0112
251 HEPATITIS C 135 0.0112
252 HEPATIC FAILURE 337 0.0112
253 HEPATITIS FULMINANT 33 0.0111
254 STRABISMUS 32 0.0109
255 QUADRIPARESIS 18 0.0108
256 HYDROCEPHALUS 58 0.0106
257 HYPERLIPIDAEMIA 127 0.0106
258 PSYCHOTIC DISORDER 309 0.0105
259 TETANY 19 0.0104
260 HEPATIC NECROSIS 39 0.0103
261 DRUG EXPOSURE DURING PREGNANCY 351 0.0103
262 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 34 0.0103
263 SPLENOMEGALY 120 0.0102
264 PNEUMONIA PNEUMOCOCCAL 15 0.0101
265 HEPATITIS CHOLESTATIC 60 0.0100
266 OSTEOPOROTIC FRACTURE 19 0.0099
267 PREMATURE DELIVERY 158 0.0099
268 PRE-ECLAMPSIA 47 0.0099
269 ACUTE LYMPHOCYTIC LEUKAEMIA 28 0.0099
270 SPEECH DISORDER DEVELOPMENTAL 28 0.0098
271 VITRITIS 18 0.0097
272 VACCINATION FAILURE 16 0.0096
273 HEPATOCELLULAR CARCINOMA 73 0.0096
274 EXPOSURE VIA BREAST MILK 38 0.0095
275 DRUG-INDUCED LIVER INJURY 298 0.0095
276 ORAL CANDIDIASIS 124 0.0094
277 PROTEINURIA 179 0.0094
278 ECTOPIC PREGNANCY 28 0.0091
279 NEONATAL RESPIRATORY DISTRESS SYNDROME 32 0.0090
280 TRANSPLANT DYSFUNCTION 16 0.0090
281 MYELOPATHY 17 0.0089
282 ENCEPHALITIS 61 0.0088
283 LIVER TRANSPLANT 32 0.0088
284 JC VIRUS INFECTION 14 0.0088
285 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 14 0.0087
286 JAUNDICE 235 0.0087
287 HEPATIC CIRRHOSIS 162 0.0086
288 AREFLEXIA 23 0.0086
289 PRESCRIBED OVERDOSE 166 0.0086
290 BRADYARRHYTHMIA 14 0.0085
291 COELIAC DISEASE 83 0.0085
292 HEPATITIS TOXIC 22 0.0084
293 LUNG NEOPLASM 36 0.0084
294 COMPLICATIONS OF TRANSPLANTED KIDNEY 19 0.0084
295 GRANULOMA 29 0.0084
296 HYPERPARATHYROIDISM 17 0.0082
297 LACTIC ACIDOSIS 267 0.0082
298 CHOLELITHIASIS 270 0.0082
299 ALANINE AMINOTRANSFERASE INCREASED 502 0.0082
300 APLASIA PURE RED CELL 28 0.0081
301 ABORTION SPONTANEOUS 326 0.0081
302 LYMPHADENOPATHY 287 0.0081
303 CUSHINGOID 26 0.0081
304 DERMATITIS EXFOLIATIVE 40 0.0080
305 STEVENS-JOHNSON SYNDROME 177 0.0080
306 BLOOD BICARBONATE DECREASED 15 0.0079
307 NORMAL NEWBORN 43 0.0079
308 ACUTE HEPATIC FAILURE 108 0.0079
309 LICHENOID KERATOSIS 18 0.0079
310 TRANSPLANT REJECTION 63 0.0079
311 LYMPHADENOPATHY MEDIASTINAL 15 0.0078
312 PARANOIA 135 0.0078
313 INTRACRANIAL PRESSURE INCREASED 43 0.0077
314 BK VIRUS INFECTION 26 0.0077
315 BILIRUBIN CONJUGATED INCREASED 18 0.0077
316 HEPATITIS 196 0.0077
317 NEUROLOGICAL SYMPTOM 43 0.0075
318 RENAL COLIC 17 0.0075
319 LUNG ADENOCARCINOMA 22 0.0073
320 PREMATURE LABOUR 41 0.0072
321 CLEFT PALATE 14 0.0072
322 DYSMORPHISM 17 0.0072
323 HYPERPARATHYROIDISM SECONDARY 18 0.0072
324 MYOPATHY 62 0.0072
325 OCULAR ICTERUS 31 0.0071
326 FIBROSIS 22 0.0071
327 ATTENTION DEFICIT HYPERACTIVITY DISORDER 30 0.0071
328 PATHOLOGICAL FRACTURE 36 0.0071
329 IMMUNODEFICIENCY 105 0.0070
330 DIPLOPIA 181 0.0070
331 BURSITIS 84 0.0069
332 ASPARTATE AMINOTRANSFERASE INCREASED 367 0.0069
333 HISTIOCYTOSIS HAEMATOPHAGIC 20 0.0067
334 INSULIN RESISTANCE 14 0.0067
335 FOETAL DISTRESS SYNDROME 14 0.0066
336 OLIGOHYDRAMNIOS 22 0.0066
337 PNEUMOCYSTIS JIROVECII PNEUMONIA 66 0.0066
338 ASCITES 192 0.0065
339 CREATININE RENAL CLEARANCE DECREASED 26 0.0065
340 HAEMANGIOMA 15 0.0065
341 OSTEOPENIA 98 0.0065
342 DRUG LEVEL BELOW THERAPEUTIC 35 0.0063
343 HYPERURICAEMIA 26 0.0063
344 MYOPIA 15 0.0063
345 PARESIS 14 0.0063
346 CONGESTIVE CARDIOMYOPATHY 26 0.0062
347 BLOOD URIC ACID INCREASED 36 0.0062
348 BLOOD PHOSPHORUS INCREASED 17 0.0062
349 ENTEROCOCCAL INFECTION 30 0.0062
350 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 298 0.0062
351 LEUKOENCEPHALOPATHY 23 0.0062
352 TRANSAMINASES INCREASED 137 0.0062
353 PREGNANCY 123 0.0061
354 RENAL TUBULAR NECROSIS 60 0.0061
355 GAMMA-GLUTAMYLTRANSFERASE INCREASED 135 0.0061
356 CONGENITAL ANOMALY 47 0.0061
357 BLOOD ALBUMIN DECREASED 48 0.0060
358 FEMORAL NECK FRACTURE 31 0.0060
359 HEPATIC CYTOLYSIS 77 0.0060
360 CYTOLYTIC HEPATITIS 20 0.0060
361 DRUG TOXICITY 82 0.0060
362 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 14 0.0060
363 RENAL IMPAIRMENT 499 0.0059
364 BLOOD ALKALINE PHOSPHATASE INCREASED 147 0.0059
365 BACTERIAL SEPSIS 19 0.0058
366 MATERNAL EXPOSURE DURING PREGNANCY 517 0.0058
367 TOXIC EPIDERMAL NECROLYSIS 88 0.0058
368 OSTEOPOROSIS 237 0.0058
369 ATAXIA 68 0.0057
370 STAPHYLOCOCCAL SEPSIS 28 0.0057
371 PERIPHERAL ISCHAEMIA 23 0.0056
372 NEPHROPATHY 52 0.0056
373 BLOOD TRIGLYCERIDES INCREASED 98 0.0055
374 METABOLIC ACIDOSIS 175 0.0055
375 HEPATIC ENZYME INCREASED 371 0.0054
376 CYTOMEGALOVIRUS INFECTION 90 0.0054
377 ANHEDONIA 141 0.0054
378 UMBILICAL HERNIA 25 0.0053
379 DISSEMINATED INTRAVASCULAR COAGULATION 75 0.0053
380 HYPERCHOLESTEROLAEMIA 51 0.0053
381 EPSTEIN-BARR VIRUS INFECTION 33 0.0053
382 CANDIDIASIS 21 0.0052
383 LIPASE INCREASED 40 0.0052
384 PROTEIN URINE PRESENT 26 0.0052
385 NECROSIS 29 0.0052
386 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 39 0.0052
387 HEPATIC FUNCTION ABNORMAL 193 0.0052
388 METABOLIC DISORDER 30 0.0052
389 TORSADE DE POINTES 40 0.0051
390 TACHYPNOEA 69 0.0051
391 CREPITATIONS 15 0.0050
392 BRAIN HERNIATION 15 0.0050
393 GASTROENTERITIS 73 0.0050
394 MALABSORPTION 26 0.0050
395 MULTI-ORGAN FAILURE 86 0.0050
396 BRONCHOPNEUMONIA 17 0.0050
397 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
398 CHOLESTASIS 94 0.0049
399 HYPOALBUMINAEMIA 38 0.0049
400 ECONOMIC PROBLEM 74 0.0049
401 PAPILLOEDEMA 22 0.0049
402 NEPHROTIC SYNDROME 33 0.0048
403 ANOREXIA 62 0.0048
404 MACULOPATHY 17 0.0048
405 END STAGE RENAL DISEASE 87 0.0048
406 HERPES SIMPLEX 31 0.0048
407 HEPATITIS ACUTE 31 0.0048
408 HERPES VIRUS INFECTION 27 0.0047
409 DEPRESSION 1062 0.0047
410 DRUG LEVEL INCREASED 77 0.0046
411 LOW DENSITY LIPOPROTEIN INCREASED 36 0.0046
412 FAILURE TO THRIVE 24 0.0046
413 HEMIPLEGIA 38 0.0046
414 DYSAESTHESIA 14 0.0046
415 CEREBRAL ATROPHY 18 0.0045
416 VISUAL FIELD DEFECT 32 0.0044
417 POLYNEUROPATHY 53 0.0044
418 HEPATIC STEATOSIS 82 0.0044
419 GOITRE 18 0.0044
420 BLOOD CREATININE INCREASED 287 0.0044
421 CENTRAL NERVOUS SYSTEM LESION 60 0.0044
422 RASH MACULO-PAPULAR 96 0.0043
423 ADRENAL INSUFFICIENCY 52 0.0043
424 BRAIN OEDEMA 54 0.0043
425 ILEUS PARALYTIC 19 0.0043
426 HEART DISEASE CONGENITAL 15 0.0042
427 AUTOIMMUNE THYROIDITIS 16 0.0042
428 ANAEMIA 804 0.0042
429 ATRIOVENTRICULAR BLOCK COMPLETE 28 0.0042
430 KLEBSIELLA INFECTION 21 0.0041
431 RENAL FAILURE ACUTE 176 0.0041
432 HEPATIC CYST 14 0.0041
433 NEUROTOXICITY 72 0.0041
434 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 70 0.0041
435 LUNG INFILTRATION 36 0.0041
436 NEUTROPENIC SEPSIS 29 0.0041
437 ACIDOSIS 31 0.0041
438 BLOOD CREATININE ABNORMAL 14 0.0040
439 MENINGITIS 27 0.0040
440 PATENT DUCTUS ARTERIOSUS 16 0.0040
441 HYPERREFLEXIA 14 0.0040
442 OSTEONECROSIS 132 0.0040
443 CAROTID ARTERY STENOSIS 14 0.0040
444 GESTATIONAL DIABETES 19 0.0040
445 COAGULOPATHY 66 0.0040
446 RALES 23 0.0040
447 GUILLAIN-BARRE SYNDROME 19 0.0039
448 PANCYTOPENIA 218 0.0039
449 BRONCHOPULMONARY ASPERGILLOSIS 30 0.0039
450 CYTOMEGALOVIRUS INFECTION REACTIVATION 17 0.0038
451 LIVER INJURY 94 0.0038
452 AMYLASE INCREASED 14 0.0038
453 MALNUTRITION 42 0.0038
454 BLOOD CREATINE PHOSPHOKINASE INCREASED 108 0.0037
455 AUTOIMMUNE HEPATITIS 26 0.0037
456 TUBULOINTERSTITIAL NEPHRITIS 70 0.0037
457 HYPOTONIA 37 0.0037
458 PROTHROMBIN TIME PROLONGED 22 0.0037
459 GLOMERULAR FILTRATION RATE DECREASED 45 0.0037
460 BONE MARROW FAILURE 74 0.0036
461 IMMUNOSUPPRESSION 32 0.0036
462 CYTOMEGALOVIRUS VIRAEMIA 16 0.0036
463 DEFAECATION URGENCY 25 0.0036
464 CHOLANGITIS 22 0.0035
465 KIDNEY TRANSPLANT REJECTION 17 0.0035
466 HYPERPYREXIA 15 0.0035
467 HEMIPARESIS 60 0.0035
468 PURPURA 31 0.0035
469 HAEMOLYSIS 27 0.0035
470 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
471 PNEUMONIA BACTERIAL 32 0.0035
472 BLOOD LACTATE DEHYDROGENASE INCREASED 55 0.0035
473 RENAL FAILURE 458 0.0034
474 LYMPHOMA 53 0.0034
475 BOWEL MOVEMENT IRREGULARITY 26 0.0034
476 ENCEPHALOPATHY 83 0.0034
477 CHRONIC KIDNEY DISEASE 255 0.0034
478 BONE DENSITY DECREASED 105 0.0033
479 APPETITE DISORDER 22 0.0033
480 HYPERTHYROIDISM 48 0.0033
481 THROMBOCYTOPENIA 368 0.0033
482 PAPULE 23 0.0033
483 SKIN LESION 88 0.0032
484 HYDRONEPHROSIS 24 0.0032
485 SKIN PLAQUE 27 0.0032
486 SKIN TOXICITY 18 0.0032
487 HYPERTONIA 18 0.0031
488 MULTIPLE ORGAN DYSFUNCTION SYNDROME 89 0.0031
489 NERVOUS SYSTEM DISORDER 98 0.0031
490 HYPOVOLAEMIC SHOCK 15 0.0031
491 SUBCUTANEOUS ABSCESS 15 0.0031
492 MENINGITIS ASEPTIC 14 0.0031
493 PANCREATITIS ACUTE 70 0.0031
494 SOCIAL AVOIDANT BEHAVIOUR 18 0.0031
495 SKIN NECROSIS 16 0.0031
496 DECREASED IMMUNE RESPONSIVENESS 30 0.0031
497 ABDOMINAL TENDERNESS 15 0.0030
498 SEPTIC SHOCK 131 0.0030
499 CORONARY ARTERY STENOSIS 15 0.0030
500 CONTRAINDICATED PRODUCT ADMINISTERED 90 0.0030
501 RASH ERYTHEMATOUS 142 0.0030
502 LEUKOPENIA 148 0.0030
503 BEHAVIOUR DISORDER 16 0.0030
504 DRUG LEVEL DECREASED 30 0.0029
505 LIVER FUNCTION TEST ABNORMAL 85 0.0029
506 VASCULITIS 34 0.0029
507 SKIN HYPERPIGMENTATION 25 0.0029
508 INTESTINAL ISCHAEMIA 16 0.0029
509 DEVELOPMENTAL DELAY 26 0.0029
510 VITAMIN D DEFICIENCY 28 0.0029
511 PARTIAL SEIZURES 15 0.0029
512 CHOLECYSTITIS ACUTE 16 0.0028
513 GRAND MAL CONVULSION 26 0.0028
514 HEPATIC ENZYME ABNORMAL 14 0.0028
515 RESPIRATORY DISTRESS 77 0.0028
516 PYREXIA 963 0.0028
517 ACUTE MYOCARDIAL INFARCTION 81 0.0027
518 REBOUND EFFECT 31 0.0027
519 HAEMATOTOXICITY 26 0.0027
520 DISEASE RECURRENCE 130 0.0027
521 LIVER DISORDER 121 0.0027
522 NO THERAPEUTIC RESPONSE 33 0.0027
523 PANCREATITIS 143 0.0027
524 DERMATITIS ALLERGIC 34 0.0027
525 LUNG NEOPLASM MALIGNANT 111 0.0027
526 MULTIPLE FRACTURES 44 0.0027
527 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 139 0.0027
528 RHABDOMYOLYSIS 111 0.0027
529 PYELONEPHRITIS 23 0.0027
530 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 23 0.0026
531 STRESS FRACTURE 14 0.0026
532 GENERALISED OEDEMA 32 0.0026
533 HYPOKALAEMIA 119 0.0026
534 PSEUDOMONAS INFECTION 22 0.0026
535 POLYURIA 21 0.0026
536 TYPE 1 DIABETES MELLITUS 15 0.0025
537 APLASTIC ANAEMIA 13 0.0025
538 ELECTROCARDIOGRAM QT PROLONGED 89 0.0025
539 RENAL FAILURE CHRONIC 19 0.0025
540 UPPER RESPIRATORY TRACT INFECTION 114 0.0025
541 MAJOR DEPRESSION 18 0.0025
542 ASPERGILLUS INFECTION 16 0.0024
543 HYPERKALAEMIA 85 0.0024
544 OLIGURIA 15 0.0024
545 RESPIRATORY FAILURE 176 0.0024
546 ELECTROLYTE IMBALANCE 28 0.0024
547 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 23 0.0024
548 SEPSIS 268 0.0024
549 NEPHROLITHIASIS 110 0.0024
550 STATUS EPILEPTICUS 27 0.0024
551 HYPERGLYCAEMIA 87 0.0024
552 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
553 NEUROPATHY PERIPHERAL 225 0.0024
554 RESPIRATORY RATE INCREASED 21 0.0024
555 ERYTHEMA MULTIFORME 22 0.0024
556 ODYNOPHAGIA 14 0.0023
557 HAEMOLYTIC ANAEMIA 21 0.0023
558 ENDOPHTHALMITIS 14 0.0023
559 HEPATOCELLULAR INJURY 33 0.0023
560 GYNAECOMASTIA 72 0.0023
561 NEUTROPENIA 316 0.0023
562 ANURIA 20 0.0023
563 GASTRITIS 61 0.0023
564 BRADYPHRENIA 15 0.0023
565 UVEITIS 31 0.0023
566 PALLOR 62 0.0023
567 PARKINSONISM 22 0.0023
568 RENAL INJURY 67 0.0023
569 SINUS TACHYCARDIA 32 0.0023
570 BACTERIAL INFECTION 42 0.0022
571 THERAPY NON-RESPONDER 101 0.0022
572 SKIN MASS 15 0.0022
573 FEBRILE NEUTROPENIA 149 0.0022
574 MUCOSAL INFLAMMATION 58 0.0022
575 MUSCLE ATROPHY 28 0.0022
576 PULMONARY HYPERTENSION 46 0.0022
577 DRUG ERUPTION 39 0.0022
578 RASH PUSTULAR 16 0.0022
579 CANDIDA INFECTION 37 0.0022
580 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 56 0.0022
581 HYPERTRANSAMINASAEMIA 15 0.0022
582 CONJUNCTIVITIS 40 0.0022
583 DIARRHOEA HAEMORRHAGIC 20 0.0021
584 RIB FRACTURE 44 0.0021
585 DELIRIUM 74 0.0021
586 ACUTE KIDNEY INJURY 326 0.0021
587 BLOOD SODIUM DECREASED 40 0.0021
588 LYMPHOPENIA 30 0.0021
589 MITRAL VALVE INCOMPETENCE 24 0.0021
590 CARDIOMEGALY 26 0.0021
591 RHINITIS 17 0.0021
592 CHOLECYSTITIS 25 0.0021
593 CONDITION AGGRAVATED 635 0.0021
594 DERMATITIS BULLOUS 15 0.0021
595 DRUG INTOLERANCE 200 0.0021
596 EYELID OEDEMA 24 0.0021
597 RENAL DISORDER 95 0.0020
598 PERICARDIAL EFFUSION 47 0.0020
599 CEREBRAL DISORDER 15 0.0020
600 ARTERIOSCLEROSIS 19 0.0020
601 DIABETES MELLITUS 153 0.0020
602 GENERALISED TONIC-CLONIC SEIZURE 33 0.0020
603 CHROMATURIA 45 0.0020
604 CARDIOMYOPATHY 29 0.0020
605 OEDEMA PERIPHERAL 238 0.0020
606 GRAFT VERSUS HOST DISEASE 14 0.0019
607 ABSCESS 31 0.0019
608 BACTERAEMIA 23 0.0019
609 SPINAL COMPRESSION FRACTURE 16 0.0019
610 PHARYNGITIS 24 0.0019
611 APPENDICITIS 18 0.0019
612 VENTRICULAR EXTRASYSTOLES 20 0.0019
613 INTENTIONAL PRODUCT USE ISSUE 168 0.0019
614 PNEUMOTHORAX 30 0.0019
615 WHEEZING 112 0.0019
616 SUICIDAL IDEATION 172 0.0019
617 FLUID RETENTION 95 0.0019
618 QUALITY OF LIFE DECREASED 25 0.0019
619 SKIN ULCER 48 0.0019
620 UPPER GASTROINTESTINAL HAEMORRHAGE 31 0.0018
621 GASTROINTESTINAL DISORDER 165 0.0018
622 PLEURAL EFFUSION 112 0.0018
623 AGRANULOCYTOSIS 34 0.0018
624 ESCHERICHIA INFECTION 15 0.0018
625 TENDERNESS 19 0.0018
626 IMMUNE SYSTEM DISORDER 24 0.0018
627 TUMOUR LYSIS SYNDROME 16 0.0018
628 DIFFUSE LARGE B-CELL LYMPHOMA 14 0.0018
629 VOMITING 852 0.0018
630 HAEMOGLOBIN DECREASED 185 0.0018
631 DEAFNESS 47 0.0018
632 BRAIN INJURY 18 0.0018
633 MASS 25 0.0018
634 HAEMODIALYSIS 15 0.0018
635 MYOSITIS 16 0.0018
636 DYSARTHRIA 67 0.0018
637 FACE OEDEMA 30 0.0018
638 FACIAL PARALYSIS 15 0.0018
639 DYSPHAGIA 167 0.0018
640 THROMBOTIC MICROANGIOPATHY 17 0.0017
641 APHASIA 52 0.0017
642 WEIGHT FLUCTUATION 18 0.0017
643 URINE OUTPUT DECREASED 15 0.0017
644 GASTROOESOPHAGEAL REFLUX DISEASE 138 0.0017
645 EOSINOPHILIA 30 0.0017
646 GENERAL PHYSICAL HEALTH DETERIORATION 195 0.0017
647 CORONARY ARTERY DISEASE 51 0.0017
648 TENDONITIS 26 0.0017
649 SEROTONIN SYNDROME 32 0.0017
650 HAEMATURIA 57 0.0017
651 ACUTE RESPIRATORY FAILURE 32 0.0017
652 TYPE 2 DIABETES MELLITUS 56 0.0017
653 OEDEMA 90 0.0017
654 HAEMATEMESIS 42 0.0017
655 AMENORRHOEA 29 0.0017
656 INFUSION RELATED REACTION 109 0.0016
657 PNEUMONIA 532 0.0016
658 BLOOD MAGNESIUM DECREASED 14 0.0016
659 HYPERCALCAEMIA 20 0.0016
660 BLOOD UREA INCREASED 27 0.0016
661 NODULE 21 0.0016
662 VISUAL ACUITY REDUCED 53 0.0016
663 CONVULSION 90 0.0016
664 ULCER 25 0.0016
665 BONE PAIN 92 0.0016
666 MYOCARDITIS 18 0.0016
667 MOUTH ULCERATION 33 0.0016
668 HYPONATRAEMIA 88 0.0016
669 HYPOXIA 55 0.0016
670 RASH PAPULAR 35 0.0016
671 DIALYSIS 22 0.0015
672 ACUTE MYELOID LEUKAEMIA 24 0.0015
673 PARALYSIS 22 0.0015
674 HYPOCALCAEMIA 29 0.0015
675 BLOOD CALCIUM DECREASED 17 0.0015
676 COORDINATION ABNORMAL 21 0.0015
677 TOXIC SKIN ERUPTION 15 0.0015
678 HYPOTHERMIA 15 0.0015
679 FOOT FRACTURE 28 0.0015
680 INTERNATIONAL NORMALISED RATIO INCREASED 42 0.0015
681 VIRAL INFECTION 49 0.0015
682 BLINDNESS 60 0.0015
683 CYANOSIS 23 0.0015
684 HYPERHIDROSIS 188 0.0015
685 C-REACTIVE PROTEIN INCREASED 53 0.0015
686 STAPHYLOCOCCAL INFECTION 48 0.0015
687 TOXICITY TO VARIOUS AGENTS 244 0.0014
688 WEIGHT DECREASED 403 0.0014
689 FOOT DEFORMITY 16 0.0014
690 MENTAL STATUS CHANGES 40 0.0014
691 APATHY 21 0.0014
692 HYPERTENSION 304 0.0014
693 ABDOMINAL PAIN 332 0.0014
694 INCONTINENCE 15 0.0014
695 DISORIENTATION 56 0.0014
696 PULMONARY MASS 21 0.0014
697 VENTRICULAR TACHYCARDIA 23 0.0014
698 SHOCK 32 0.0014
699 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
700 PLATELET COUNT INCREASED 18 0.0014
701 EMOTIONAL DISTRESS 167 0.0014
702 INFECTION 199 0.0014
703 LETHARGY 79 0.0014
704 ILEUS 17 0.0014
705 RESTLESSNESS 50 0.0014
706 ERECTILE DYSFUNCTION 35 0.0014
707 HAEMOPTYSIS 38 0.0014
708 TACHYCARDIA 121 0.0014
709 HAEMATOCRIT DECREASED 27 0.0014
710 NERVE INJURY 15 0.0013
711 RESPIRATORY TRACT INFECTION 35 0.0013
712 INTENTIONAL PRODUCT MISUSE 117 0.0013
713 MENTAL DISORDER 58 0.0013
714 ABDOMINAL DISTENSION 139 0.0013
715 DYSPNOEA EXERTIONAL 50 0.0013
716 SUBDURAL HAEMATOMA 19 0.0013
717 SUDDEN DEATH 14 0.0013
718 METASTASES TO CENTRAL NERVOUS SYSTEM 17 0.0013
719 MELAENA 29 0.0013
720 RASH GENERALISED 34 0.0013
721 MUSCLE SPASTICITY 16 0.0013
722 METASTASES TO LUNG 15 0.0013
723 DECREASED ACTIVITY 14 0.0013
724 BLOOD POTASSIUM INCREASED 21 0.0013
725 MUSCULAR WEAKNESS 145 0.0013
726 LEUKOCYTOSIS 23 0.0013
727 PLATELET COUNT DECREASED 135 0.0013
728 BONE DISORDER 23 0.0013
729 ANXIETY 359 0.0013
730 HALLUCINATION, AUDITORY 20 0.0013
731 HYPERTENSIVE CRISIS 14 0.0013
732 PERITONITIS 26 0.0013
733 HERPES ZOSTER 72 0.0013
734 MOVEMENT DISORDER 40 0.0012
735 BLOOD CHOLESTEROL INCREASED 58 0.0012
736 NIGHTMARE 43 0.0012
737 NIGHT SWEATS 40 0.0012
738 CORONARY ARTERY OCCLUSION 17 0.0012
739 BODY TEMPERATURE INCREASED 25 0.0012
740 LUNG INFECTION 19 0.0012
741 HYPOPHAGIA 31 0.0012
742 INFLAMMATION 62 0.0012
743 SPINAL PAIN 14 0.0012
744 DISEASE PROGRESSION 140 0.0012
745 ASTHENIA 443 0.0012
746 DECREASED APPETITE 272 0.0012
747 HYPOKINESIA 17 0.0012
748 HYPERSENSITIVITY 217 0.0012
749 MYALGIA 198 0.0012
750 HYPOTHYROIDISM 37 0.0012
751 PHOTOSENSITIVITY REACTION 19 0.0011
752 PRODUCT USE IN UNAPPROVED INDICATION 282 0.0011
753 INTERSTITIAL LUNG DISEASE 55 0.0011
754 PERICARDITIS 19 0.0011
755 CONFUSIONAL STATE 182 0.0011
756 DEEP VEIN THROMBOSIS 73 0.0011
757 PNEUMONIA ASPIRATION 28 0.0011
758 TOOTH LOSS 23 0.0011
759 GASTRIC ULCER 21 0.0011
760 NAUSEA 873 0.0011
761 PNEUMONITIS 30 0.0011
762 LUNG DISORDER 53 0.0011
763 RETCHING 23 0.0011
764 PULMONARY OEDEMA 48 0.0011
765 COMA 51 0.0011
766 COGNITIVE DISORDER 50 0.0011
767 DISTURBANCE IN ATTENTION 57 0.0011
768 MYELOSUPPRESSION 38 0.0011
769 RED BLOOD CELL COUNT DECREASED 30 0.0010
770 MYELODYSPLASTIC SYNDROME 15 0.0010
771 CEREBRAL HAEMORRHAGE 37 0.0010
772 RASH 446 0.0010
773 DIARRHOEA 660 0.0010
774 ABNORMAL DREAMS 28 0.0010
775 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 72 0.0010
776 PHOTOPHOBIA 19 0.0010
777 FRACTURE 19 0.0010
778 ASTHMA 113 0.0010
779 BONE LOSS 15 0.0010
780 AGITATION 73 0.0010
781 SLEEP DISORDER 70 0.0010
782 PRODUCTIVE COUGH 47 0.0010
783 NEUTROPHIL COUNT DECREASED 40 0.0010
784 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
785 ABASIA 24 0.0010
786 JOINT SWELLING 117 0.0010
787 MUSCULOSKELETAL CHEST PAIN 15 0.0010
788 DIABETIC KETOACIDOSIS 23 0.0010
789 DERMATITIS 20 0.0010
790 RHEUMATOID ARTHRITIS 108 0.0010
791 ANGIOEDEMA 42 0.0009
792 NEURALGIA 23 0.0009
793 COUGH 264 0.0009
794 CEREBRAL INFARCTION 23 0.0009
795 SENSORY DISTURBANCE 15 0.0009
796 IRRITABILITY 56 0.0009
797 DEHYDRATION 123 0.0009
798 NEOPLASM PROGRESSION 32 0.0009
799 EPILEPSY 28 0.0009
800 RASH MACULAR 32 0.0009
801 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
802 DEVICE RELATED INFECTION 14 0.0009
803 CARDIAC ARREST 75 0.0009
804 HYPOTENSION 182 0.0009
805 LYMPHOCYTE COUNT DECREASED 16 0.0009
806 LOWER RESPIRATORY TRACT INFECTION 41 0.0009
807 SPINAL FRACTURE 18 0.0009
808 CARDIAC FAILURE 72 0.0009
809 ISCHAEMIC STROKE 16 0.0009
810 MUSCULOSKELETAL DISORDER 17 0.0009
811 SWELLING FACE 58 0.0009
812 PSORIASIS 116 0.0009
813 PULMONARY EMBOLISM 84 0.0009
814 CHILLS 103 0.0009
815 MOBILITY DECREASED 63 0.0009
816 CELLULITIS 44 0.0009
817 PRODUCT USE ISSUE 164 0.0009
818 OVERDOSE 188 0.0009
819 RESPIRATORY DISORDER 26 0.0009
820 DISCOMFORT 53 0.0009
821 WHITE BLOOD CELL COUNT DECREASED 94 0.0009
822 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
823 HALLUCINATION, VISUAL 18 0.0009
824 EYE DISORDER 28 0.0009
825 OFF LABEL USE 745 0.0008
826 BACK PAIN 197 0.0008
827 CYTOKINE RELEASE SYNDROME 17 0.0008
828 URINARY INCONTINENCE 25 0.0008
829 FEMUR FRACTURE 26 0.0008
830 ANGINA PECTORIS 24 0.0008
831 GOUT 15 0.0008
832 BLOOD POTASSIUM DECREASED 25 0.0008
833 GASTROINTESTINAL HAEMORRHAGE 69 0.0008
834 GAIT DISTURBANCE 157 0.0008
835 ORAL HERPES 16 0.0008
836 ERYTHEMA 168 0.0008
837 DEPRESSED MOOD 43 0.0008
838 DRUG INEFFECTIVE 1071 0.0008
839 RASH PRURITIC 44 0.0008
840 HYPOAESTHESIA 119 0.0008
841 LIVER FUNCTION TEST INCREASED 17 0.0008
842 SKIN EXFOLIATION 66 0.0008
843 ARRHYTHMIA 37 0.0008
844 ADVERSE EVENT 71 0.0008
845 DRUG ABUSE 64 0.0008
846 HYPOGLYCAEMIA 37 0.0008
847 PALPITATIONS 88 0.0008
848 SKIN DISORDER 25 0.0007
849 DEATH 645 0.0007
850 IMPAIRED WORK ABILITY 16 0.0007
851 CARDIOVASCULAR DISORDER 19 0.0007
852 PLASMA CELL MYELOMA 29 0.0007
853 POOR QUALITY SLEEP 16 0.0007
854 HALLUCINATION 56 0.0007
855 THERAPEUTIC RESPONSE DECREASED 45 0.0007
856 SUICIDE ATTEMPT 45 0.0007
857 MUSCULOSKELETAL STIFFNESS 65 0.0007
858 PRURITUS GENERALISED 16 0.0007
859 UNRESPONSIVE TO STIMULI 19 0.0007
860 OSTEOARTHRITIS 31 0.0007
861 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
862 MYOCARDIAL INFARCTION 126 0.0007
863 CARDIO-RESPIRATORY ARREST 30 0.0007
864 BRADYCARDIA 38 0.0007
865 PAIN 437 0.0007
866 CONSTIPATION 155 0.0007
867 CHEST PAIN 131 0.0007
868 MOOD ALTERED 19 0.0007
869 FATIGUE 540 0.0007
870 HEADACHE 430 0.0007
871 SEIZURE 79 0.0007
872 AGGRESSION 34 0.0007
873 DYSURIA 25 0.0007
874 SOMNOLENCE 135 0.0007
875 DYSKINESIA 27 0.0007
876 CHEST DISCOMFORT 68 0.0007
877 MALAISE 285 0.0006
878 SYNCOPE 65 0.0006
879 ATRIAL FIBRILLATION 63 0.0006
880 EPISTAXIS 48 0.0006
881 LOSS OF CONSCIOUSNESS 82 0.0006
882 COLITIS 24 0.0006
883 BLOOD PRESSURE DECREASED 42 0.0006
884 SKIN DISCOLOURATION 29 0.0006
885 WEIGHT INCREASED 141 0.0006
886 ACCIDENTAL OVERDOSE 23 0.0006
887 VERTIGO 38 0.0006
888 PRESYNCOPE 15 0.0006
889 DIZZINESS 305 0.0006
890 PAIN IN EXTREMITY 180 0.0006
891 INTESTINAL OBSTRUCTION 23 0.0006
892 URINARY TRACT INFECTION 104 0.0006
893 ABNORMAL BEHAVIOUR 24 0.0006
894 PANIC ATTACK 22 0.0006
895 INSOMNIA 159 0.0006
896 STOMATITIS 36 0.0006
897 ABDOMINAL PAIN LOWER 15 0.0006
898 ARTHRALGIA 246 0.0006
899 OXYGEN SATURATION DECREASED 33 0.0006
900 PARAESTHESIA 92 0.0006
901 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
902 DYSSTASIA 17 0.0006
903 DYSPNOEA 328 0.0006
904 SPEECH DISORDER 30 0.0006
905 URINARY RETENTION 19 0.0006
906 TINNITUS 26 0.0006
907 HYPERSOMNIA 16 0.0006
908 HAEMORRHAGE 58 0.0006
909 ABDOMINAL PAIN UPPER 109 0.0005
910 FEAR 14 0.0005
911 MUSCULOSKELETAL PAIN 27 0.0005
912 RECTAL HAEMORRHAGE 22 0.0005
913 ILL-DEFINED DISORDER 31 0.0005
914 POLLAKIURIA 21 0.0005
915 HOSPITALISATION 76 0.0005
916 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
917 COVID-19 86 0.0005
918 CARDIAC FAILURE CONGESTIVE 39 0.0005
919 EYE SWELLING 18 0.0005
920 BLISTER 27 0.0005
921 AMNESIA 31 0.0005
922 SWELLING 44 0.0005
923 VISION BLURRED 63 0.0005
924 NO ADVERSE EVENT 83 0.0005
925 GAIT INABILITY 15 0.0004
926 NECK PAIN 25 0.0004
927 TREMOR 73 0.0004
928 GASTRIC DISORDER 15 0.0004
929 DYSPEPSIA 42 0.0004
930 HEART RATE INCREASED 42 0.0004
931 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
932 CATARACT 24 0.0004
933 MEMORY IMPAIRMENT 55 0.0004
934 FALL 132 0.0004
935 PRURITUS 150 0.0004
936 ABDOMINAL DISCOMFORT 65 0.0004
937 THROMBOSIS 31 0.0004
938 CEREBROVASCULAR ACCIDENT 65 0.0004
939 SINUSITIS 39 0.0004
940 HAEMATOCHEZIA 21 0.0004
941 OCULAR HYPERAEMIA 18 0.0004
942 ADVERSE DRUG REACTION 34 0.0004
943 DYSPHONIA 22 0.0004
944 THERAPY CESSATION 19 0.0004
945 MALIGNANT NEOPLASM PROGRESSION 36 0.0004
946 NEOPLASM MALIGNANT 23 0.0003
947 FEELING HOT 21 0.0003
948 BRONCHITIS 25 0.0003
949 EYE PAIN 19 0.0003
950 DRUG EFFECT DECREASED 18 0.0003
951 DRY MOUTH 27 0.0003
952 NERVOUSNESS 17 0.0003
953 FLUSHING 33 0.0003
954 DRY EYE 16 0.0003
955 FLATULENCE 18 0.0003
956 DYSGEUSIA 23 0.0003
957 ECZEMA 16 0.0003
958 BLOOD GLUCOSE INCREASED 56 0.0003
959 URTICARIA 49 0.0003
960 ALOPECIA 57 0.0003
961 MEDICATION ERROR 16 0.0003
962 BLOOD PRESSURE INCREASED 44 0.0003
963 INFLUENZA LIKE ILLNESS 23 0.0003
964 VISUAL IMPAIRMENT 34 0.0003
965 UNDERDOSE 20 0.0003
966 ARTHROPATHY 15 0.0003
967 INTENTIONAL OVERDOSE 17 0.0003
968 MUSCLE SPASMS 48 0.0003
969 INJURY 18 0.0003
970 BALANCE DISORDER 22 0.0003
971 ARTHRITIS 20 0.0003
972 CONTUSION 24 0.0002
973 OROPHARYNGEAL PAIN 23 0.0002
974 BURNING SENSATION 16 0.0002
975 RHINORRHOEA 14 0.0002
976 COMPLETED SUICIDE 18 0.0002
977 INFLUENZA 24 0.0002
978 CARDIAC DISORDER 19 0.0002
979 FEELING ABNORMAL 43 0.0002
980 NASOPHARYNGITIS 33 0.0002
981 DRY SKIN 23 0.0002
982 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 31 0.0002
983 DRUG WITHDRAWAL SYNDROME 15 0.0002
984 INCORRECT DOSE ADMINISTERED 36 0.0002
985 MIGRAINE 15 0.0002
986 ILLNESS 16 0.0002
987 PERIPHERAL SWELLING 23 0.0001
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
989 DRUG DOSE OMISSION 16 0.0001
990 PRODUCT DOSE OMISSION ISSUE 16 0.0001